Showing results (221-230 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|May 2, 2020
Nothing is perfect: the safety issues of integrase inhibitor regimensSofía Scévola, Juan Manuel Tiraboschi, Daniel PodzamczerExpert Opinion on Drug Safety|May 4, 2021
Comparative safety review of current pharmacological treatments for interstitial cystitis/ bladder pain syndromePo-Yen Chen, Wei-Chia Lee, Yao-Chi ChuangExpert Opinion on Drug Safety|June 11, 2020
Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatmentErasmia Sampani, Pantelis Sarafidis, Aikaterini PapagianniExpert Opinion on Drug Safety|September 13, 2021
A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemiaStuart M Sprague, Markus KettelerExpert Opinion on Drug Safety|March 30, 2005
What to do with TNF failuresEdward C Keystone, Arthur KavanaughExpert Opinion on Drug Safety|March 30, 2005
The development and application of imatinibRobin L Jones, Ian R JudsonExpert Opinion on Drug Safety|April 14, 2006
Safety and tolerability of mood-stabilising anticonvulsants in the elderlyHoward H Fenn, Barbara R Sommer, Terence A Ketter, et al.Expert Opinion on Drug Safety|April 14, 2006
The safety of digoxin as a pharmacological treatment of atrial fibrillationJuan Tamargo, Eva Delpón, Ricardo CaballeroExpert Opinion on Drug Safety|August 16, 2006
Cardiac dysfunction associated with trastuzumabKaren Lisa Smith, Chau Dang, Andrew D SeidmanPageof 281